Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
7
Added to
16
Trimmed
2
Exited
8
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $9.65B across 95 positions in their Q3 2024 SEC 13F filing (period ending 2024-09-30). The top 10 positions account for 77.9% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | ONCBeiGene, Ltd. | $2.37B | 24.59% | - |
| 2 | INCYIncyte Corporation | $2.03B | 21.06% | +0.0% |
| 3 | ACADACADIA Pharmaceuticals Inc. | $659.46M | 6.83% | - |
| 4 | SMMTSummit Therapeutics Inc. | $534.90M | 5.54% | +5.2% |
| 5 | MDGLMadrigal Pharmaceuticals, Inc. | $419.05M | 4.34% | - |
| 6 | RVMDRevolution Medicines, Inc. | $343.26M | 3.56% | - |
| 7 | RYTMRhythm Pharmaceuticals, Inc. | $335.21M | 3.47% | +0.0% |
| 8 | INSMInsmed Incorporated | $322.36M | 3.34% | +23.5% |
| 9 | KYMRKymera Therapeutics, Inc. | $283.79M | 2.94% | +0.0% |
| 10 | BCYCBicycle Therapeutics plc | $212.72M | 2.20% | - |
| Stock | Value | Shares |
|---|---|---|
| BCAXBicara Therapeutics Inc. | $21.22M | 833,333 |
| ARVNArvinas, Inc. | $9.99M | 405,576 |
| IONSIonis Pharmaceuticals, Inc. | $8.95M | 223,470 |
| GPCRStructure Therapeutics Inc. | $3.75M | 85,500 |
| GPCRStructure Therapeutics Inc. | $3.75M | 85,500 |
| WVEWave Life Sciences Ltd. | $2.82M | 344,063 |
| ALGSAligos Therapeutics, Inc. | $719.26K | 83,055 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.